15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one

C52H48BIN14O6 — CID 158358671

IUPAC15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one
SMILESCn1ncc2cc(-c3ccc4c(c3)C(=O)Nc3cccc(n3)-c3nncn3CCCCO4)ccc21.Cn1ncc2cc(B(O)O)ccc21.O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(I)cc21
InChIInChI=1S/C26H23N7O2.C18H16IN5O2.C8H9BN2O2/c1-32-22-9-7-17(13-19(22)15-28-32)18-8-10-23-20(14-18)26(34)30-24-6-4-5-21(29-24)25-31-27-16-33(25)11-2-3-12-35-23;19-12-6-7-15-13(10-12)18(25)22-16-5-3-4-14(21-16)17-23-20-11-24(17)8-1-2-9-26-15;1-11-8-3-2-7(9(12)13)4-6(8)5-10-11/h4-10,13-16H,2-3,11-12H2,1H3,(H,29,30,34);3-7,10-11H,1-2,8-9H2,(H,21,22,25);2-5,12-13H,1H3
InChIKeyGTERXBNNBHKCCO-UHFFFAOYSA-N
MW1102.76 g/mol
LogP6.94
Rot. Bonds2

About 15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one

15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one (PubChem CID 158358671) has the molecular formula C52H48BIN14O6 and a molecular weight of 1102.76 g/mol. Its IUPAC name is 15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one.

Molecular Properties

Compound Name15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one
PubChem CID158358671
Molecular FormulaC52H48BIN14O6
Molecular Weight1102.76 g/mol
Exact Mass1102.30
IUPAC Name15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one
SMILESCn1ncc2cc(-c3ccc4c(c3)C(=O)Nc3cccc(n3)-c3nncn3CCCCO4)ccc21.Cn1ncc2cc(B(O)O)ccc21.O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(I)cc21
InChIInChI=1S/C26H23N7O2.C18H16IN5O2.C8H9BN2O2/c1-32-22-9-7-17(13-19(22)15-28-32)18-8-10-23-20(14-18)26(34)30-24-6-4-5-21(29-24)25-31-27-16-33(25)11-2-3-12-35-23;19-12-6-7-15-13(10-12)18(25)22-16-5-3-4-14(21-16)17-23-20-11-24(17)8-1-2-9-26-15;1-11-8-3-2-7(9(12)13)4-6(8)5-10-11/h4-10,13-16H,2-3,11-12H2,1H3,(H,29,30,34);3-7,10-11H,1-2,8-9H2,(H,21,22,25);2-5,12-13H,1H3
InChIKeyGTERXBNNBHKCCO-UHFFFAOYSA-N
XLogP6.94
TPSA239.96 Ų
H-Bond Donors4
H-Bond Acceptors18
Rotatable Bonds2
Heavy Atoms74
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001102.76
LogP ≤ 56.94
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze 15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one?
The IUPAC name of 15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one (CID 158358671) is 15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one.
What is the SMILES notation for 15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one?
The canonical SMILES for 15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one is Cn1ncc2cc(-c3ccc4c(c3)C(=O)Nc3cccc(n3)-c3nncn3CCCCO4)ccc21.Cn1ncc2cc(B(O)O)ccc21.O=C1Nc2cccc(n2)-c2nncn2CCCCOc2ccc(I)cc21.
What is the InChIKey of 15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one?
The InChIKey is GTERXBNNBHKCCO-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H23N7O2.C18H16IN5O2.C8H9BN2O2/c1-32-22-9-7-17(13-19(22)15-28-32)18-8-10-23-20(14-18)26(34)30-24-6-4-5-21(29-24)25-31-27-16-33(25)11-2-3-12-35-23;19-12-6-7-15-13(10-12)18(25)22-16-5-3-4-14(21-16)17-23-20-11-24(17)8-1-2-9-26-15;1-11-8-3-2-7(9(12)13)4-6(8)5-10-11/h4-10,13-16H,2-3,11-12H2,1H3,(H,29,30,34);3-7,10-11H,1-2,8-9H2,(H,21,22,25);2-5,12-13H,1H3.
What are the key properties of 15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one?
15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one has a molecular weight of 1102.76 g/mol, XLogP of 6.94, 2 rotatable bonds, 4 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 15-iodo-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one;(1-methylindazol-5-yl)boronic acid;15-(1-methylindazol-5-yl)-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one is sourced from PubChem (CID 158358671), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).